Molnupiravir

Pfizer to Supply 4 Million Paxlovid Doses to UNICEF

Healthcare, Investing News, Life Style, Market News, Medical Use, Pharmaceutical, Products, The Market Buzz, Your Environment

Pfizer (NYSE: PFE) is set to provide up to 4 million doses of its Covid-19 pill, Paxlovid, to low and middle-income countries amid an agreement with Unicef, the global relief organization. The pledge accounts for a little more than 3% of the company’s estimated yearly production of 120 million Paxlovid courses. [stock_market_widget type=”inline-label” template=”basic9″ color=”orange” …

Pfizer to Supply 4 Million Paxlovid Doses to UNICEF Read More »

Merck’s Covid-19 Pill Receives Approval from UK Regulators

Biotechnology, Healthcare, Investing News, Life Style, Market News, The Market Buzz, Your Environment

Merck’s (NYSE: MRK) covid-19 pill, molnupiravir, was approved by the UK Medicines and Healthcare Products Regulatory Agency on Thursday. The treatment is the first oral antiviral used to treat mild-to-moderate Covid-19 within adults that are at risk for severe illnesses. [stock_market_widget type=”inline-label” template=”basic9″ color=”orange” assets=”MRK” api=”yf”] [stock_market_widget type=”chart” template=”basic” color=”orange” assets=”MRK” range=”1mo” interval=”1d” axes=”true” cursor=”true” …

Merck’s Covid-19 Pill Receives Approval from UK Regulators Read More »

Stay Connected

Twitter Linkedin-in Instagram Facebook-f Youtube

Subscribe

Subscribe
Subscribe